Senior Advisor

Global Drug Developer (involved in all parts of Development from Research to Registration but with focus from Research to Phase II) that has generated and implemented accelerated (fast track) development processes that can reduce traditional development steps significantly.

Worked in numerous disease areas but with special knowledge in the area of endocrinology (diabetes and obesity), CNS and inflammation/pain.

A Global Network within the area of Drug Development (Industry, Regulatory and Academia).

Mikael is MSc in Pharmacy, MSc in Human Biology and PhD in Pharmacology/Toxicology and has been involved in numerous biotech companies as Chief Scientific/Development Officer.